Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019 has led to the development of a large number of vaccines, several of which are now approved for use in humans. Understanding vaccine-elicited antibody responses against emerging SARS-CoV-2 variants of concern (VOCs...

Descripción completa

Detalles Bibliográficos
Autores principales: Walls, Alexandra C., VanBlargan, Laura A., Wu, Kai, Choi, Angela, Navarro, Mary Jane, Lee, Diana, Avena, Laura, Berrueta, Daniela Montes, Pham, Minh N., Elbashir, Sayda, Kraft, John C., Miranda, Marcos C., Kepl, Elizabeth, Johnson, Max, Blackstone, Alyssa, Sprouse, Kaitlin, Fiala, Brooke, O’Connor, Megan A., Brunette, Natalie, Arunachalam, Prabhu S., Shirreff, Lisa, Rogers, Kenneth, Carter, Lauren, Fuller, Deborah H., Villinger, Francois, Pulendran, Bali, Diamond, Michael S., Edwards, Darin K., King, Neil P., Veesler, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). 2022
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376299/
https://www.ncbi.nlm.nih.gov/pubmed/35988541
http://dx.doi.org/10.1016/j.celrep.2022.111299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376299/
https://www.ncbi.nlm.nih.gov/pubmed/35988541
http://dx.doi.org/10.1016/j.celrep.2022.111299

Ejemplares similares